Clinical trial
Guided Treatment Based on Mini-PDX in Metastatic Triple Negative Breast Cancer
NCT04745975
Study timeline
Study start (actual)2021-02-01Date precision: day
Registry last updated2022-04-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Triple Negative Breast Cancerunresolved
Interventions
Nab paclitaxelDRUG
EribulinDRUG · verified · RxNorm: eribulin
VinorelbineDRUG · verified · RxNorm: vinorelbine
GemcitabineDRUG · verified · RxNorm: gemcitabine
CapecitabineDRUG · verified · RxNorm: capecitabine
Sponsors & collaborators
Fudan Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04745975 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.